|
Post by Addam603 on Mar 13, 2022 17:26:25 GMT -5
This has been said over and over again in the Wacha signing thread. Bloom isn’t paying Wacha 7 million to be the 5.00 ERA guy. He’s paying Wacha 7 million to be the pitcher he was at the end of the season last year when he made his pitch change and was an entirely new player. At the end of last season, Wacha was getting obliterated by the Red Sox in the playoffs. I’m not sure what you were watching. He’s had a negative WAR for the last 3(!!) seasons. I would have supported getting him as a non-roster guy and seeing what he could do. But for $7m??? I can’t figure it out. Read the Wacha thread. Everything is there. This is the main point though.
|
|
|
Post by Addam603 on Mar 13, 2022 17:20:13 GMT -5
Already talking about a guy sucking and cutting him before ST even starts. Boston fans are the f*cking worst We got a good long look at Wacha last year with TB. He was totally washed-up. His ERA for the last 3 seasons is over 5.00. He stinks. It is what it is. I wish that wasn’t the case, believe me. This has been said over and over again in the Wacha signing thread. Bloom isn’t paying Wacha 7 million to be the 5.00 ERA guy. He’s paying Wacha 7 million to be the pitcher he was at the end of the season last year when he made his pitch change and was an entirely new player.
|
|
|
Post by Addam603 on Mar 13, 2022 12:15:01 GMT -5
It’s taking an awfully big risk relying on Matt Barnes to be who he was in the first half of last season. The bullpen is in a state of flux with Whitlock and Houck’s role up in the air, but a back end of Barnes, Diekman, and…Brasier? Taylor? That’s not a bullpen I’d trust to hold down games for a full season. Don’t get me wrong, I like the Diekman and Strahm signings but it’s all going to depend on Houck and Whitlock.
|
|
|
Post by Addam603 on Mar 12, 2022 11:03:56 GMT -5
Hadn’t seen this reported before but I’m glad that teams were allowed to talk to their injured players evidently.
|
|
|
Post by Addam603 on Mar 12, 2022 10:25:42 GMT -5
One of the better bullpen guys is off the market.
|
|
|
Noah Song
Mar 12, 2022 8:29:39 GMT -5
via mobile
Post by Addam603 on Mar 12, 2022 8:29:39 GMT -5
I would think no news is bad news at this point. We’re well past his two year service time I believe. If he was able to/wanted to get a waiver to play this season, I would have expected him to be at the start of minor league spring training and so far there’s been no report of that. I hope I’m wrong though.
|
|
|
Post by Addam603 on Mar 11, 2022 14:47:18 GMT -5
|
|
|
Post by Addam603 on Mar 10, 2022 15:05:02 GMT -5
|
|
|
Post by Addam603 on Mar 9, 2022 14:31:44 GMT -5
I have been extremely pro-player so far in this process, but the owners made some significant moves in this last offer. More than I expected them to, honestly. I think there’s a few details to iron out and some smaller issues to debate on, but this is a framework of a deal that I think the players should accept.
|
|
|
Post by Addam603 on Mar 7, 2022 12:34:34 GMT -5
Intrasquad game, but I am very excited for Brandon Walter this year.
|
|
|
Post by Addam603 on Jan 25, 2022 17:12:22 GMT -5
If anyone speaks Japanese (or has access to a better translator that Google), this article allegedly says that Suzuki to Boston is just about a done deal. Running it through Google Translate looks to say that, but the language is funky and I wouldn’t trust that’s accurate. I haven’t seen this repeated anywhere other than that fan account, so who knows.
|
|
|
Post by Addam603 on Dec 2, 2021 20:00:32 GMT -5
I’m sure the last part of this was in jest but it blows my mind that players that are rehabbing from potentially career altering surgeries have to switch the medical professionals that they are working with because of this lockout.
|
|
|
Post by Addam603 on Dec 2, 2021 8:26:34 GMT -5
JBJ shouldn’t be counted on as being a starting OF. He should be the 4th OF and also gives them a left-handed bat off the bench. If he starts the year in the outfield then I don’t like the trade. I still think that Suzuki or Schwarber or a COF of that caliber will start the season in the outfield along with Verdugo.
As for Renfroe, Bloom is banking on his career year not being repeated again which seams logical. If Renfroe turns back into a pumpkin, this trade looks better on Bloom too.
As for the prospects, I like them. Hamilton is a low ceiling, high floor guy that can be a utility player with speed in the majors. He is probably a bench option in 2023. Binelas is intriguing with his ceiling. Was a really highly regarded prospect before the draft. He broke his hamate bone in 2020 and struggled initially in 2021. The early season struggles contributed to his fall in the draft, but I wonder if they were largely due to getting back into the swing of things and coming back from an injury. IIRC hamate injuries don’t have the shortest rehab time and can really sap a power hitter for a bit. If he’s the player that he looked like in his pro debut, then he could be a really good prospect.
|
|
|
Post by Addam603 on Dec 1, 2021 8:04:00 GMT -5
I really like this deal, though I would consider it more of a “trade deadline addition” than a signing. Paxton won’t be ready until mid season at the earliest, so I still want the Sox to go out and get another guy that can start. There’s still a bunch of guys out there that I think could be had for short money. Preferably a guy that can start and then move into the bullpen once Paxton and/or Whitlock and Houck move into the rotation. McHugh was just mentioned and another guy could be Smyly. I’d even take another sure thing starter if Bloom can get a guy for cheap. Kikuchi, Pineda, Anderson, and Hill are still out there. I’d even take a shot on Bundy, Davies, or Boyd in the right deal. Right now one of Houck/Whitlock is currently in the rotation at the start of the year and I’m just not comfortable with that if this team has true intentions of contending.
|
|
|
Post by Addam603 on Nov 28, 2021 11:38:18 GMT -5
The Rays upgraded from Wacha to Kluber for 8 million and incentives. For an extra million I'd rather have signed Kluber. At least when he pitches he consistently gets batters out. The key words here being “when he pitches.” I don’t think there’s any question that Kluber has more upside than Wacha. But Wacha at least at this point in their careers is probably more likely to pitch a full season. The Red Sox rotation has a decent amount of questions. Can Chris Sale pitch a full season coming back from Tommy John at Chris Sale quality? Can either of Tanner Houck and Garrett Whitlock stick in the rotation for a full year? Can Nick Pivetta be consistent? If you add in the question about Kluber’s health, that’s a lot that could go wrong. The Rays, with their seemingly endless pitching development, can afford to take that risk.
|
|
|
Post by Addam603 on Nov 27, 2021 22:01:22 GMT -5
If Gausman does end up getting that 5 year deal, count me very happy that the Sox aren’t reportedly in on him.
|
|
|
Post by Addam603 on Nov 27, 2021 18:47:44 GMT -5
Will the Sox probably get the value out of Wacha in this contract? Probably. Maybe. Won't be hard. Are they spending their excess money the right way so far? Not sure. Is Wacha the best option for 7 million or so? Could you get better value somewhere else? Even in a trade? Hard to tell but I lean towards the Sox could have done better if they made a trade. They probably could have gotten a better player for the same money through a trade but then they’d have to give up prospects too. At least this way you’re only losing money if it doesn’t work out.
|
|
|
Post by Addam603 on Nov 27, 2021 10:35:30 GMT -5
No incentives on the deal. It would have been ideal if it was a lower salary with incentives that would bring it up to $7, but this is just a straight $7 million. If the Sox can get 1-2 WAR out of him, I’d call it a successful signing.
|
|
|
Post by Addam603 on Nov 27, 2021 9:51:03 GMT -5
The $7 million price tags tells me two things.
1) They’re pretty comfortable/confident in his pitch change from the end of the year and that he’s going to be more like the September version of Michael Wacha.
2) They weren’t the only team on Wacha at or around that price. So if more than one team was thinking 6-7 on Wacha then there’s at least some confidence that he can stick in the rotation for the full year and give solid back end innings.
|
|
|
Post by Addam603 on Nov 27, 2021 9:23:11 GMT -5
|
|
|
Post by Addam603 on Nov 26, 2021 17:11:10 GMT -5
I like Wacha as a back end of the rotation guy. If he’s the guy they want to be their #3, then I don’t like it. Still hoping they get a Gray/Anderson type as a mid-rotation option.
|
|
|
Post by Addam603 on Nov 23, 2021 11:15:53 GMT -5
A few familiar names appeared on the BA minor league transaction thread that was released this morning.
CJ Chatham signed with the D-Backs and Hunter Haworth was released
Luis Alexander Basabe (previously with the Giants) and Jagger Rusconi re-signed with the White Sox
|
|
|
Post by Addam603 on Nov 22, 2021 11:52:15 GMT -5
Late to the party, but I'd rather stay away from the big money guys like Gausman, Ray, Stroman, etc (let alone Scherzer and Kershaw). I think the Sox should go fishing in the Cobb, Pineda, DeSclafani, Gray, Matz (among others) pool. I think they need to get at least one of that tier, but personally I would rather see them get two. Glass half-full has Houck and Whitlock as solid starters, but relying on one or both of them to throw 150+ innings shouldn't be something that a team with World Series aspirations does. Add in the fact that we still need 1-2 high leverage relievers and money for an eventual Devers extension, and I don't want to throw huge money at one person.
|
|
|
Post by Addam603 on Nov 21, 2021 11:30:30 GMT -5
The period would pause and then resume once the lockout ended with the same amount of time left.
|
|
|
Post by Addam603 on Nov 15, 2021 11:29:28 GMT -5
Always fun to remember that we got E-Rod for 20 innings of Andrew Miller. They were admittedly 20 very good innings, but we got 856.2 innings of anywhere from a solid #3 to Cy Young contending pitcher for half a year of a reliever. One of the best Red Sox trades in recent memory.
|
|